Loading stock data...
Last Updated: 10 Mar 2026, 03:30:03 PM (IST)

TTK Healthcare Limited

NSE: TTKHLTCARE

NSE
853.25 -16.95 (-1.95%)

Prev Close

870.2

Open Price

876.7

Volume

7,647

Today Low / High

846.5 / 886.9

52 WK Low / High

846.5 / 1398.9

Range

811 - 896

Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 853.25, with a change of -16.95 (-1.94783%). The expected target range on the NSE is between 811 - 896. The stock is experiencing a downward trend on the NSE. Investors should be cautious as the price is currently declining.

TTK Healthcare Limited Graph

TTK Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for TTK Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 853.25, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 853.25 861.78 775.60 - 947.96
870.32 696.25 - 1,044.38
878.85 615.19 - 1,142.50
Bearish Scenario 853.25 844.72 760.25 - 929.19
836.19 668.95 - 1,003.42
827.65 579.36 - 1,075.95

Overview of TTK Healthcare Limited

ISIN

INE910C01018

Industry

Drug Manufacturers - General

Vol.Avg

4,728

Market Cap

12,615,561,302

Last Dividend

10

Official Website

Visit Website

IPO Date

2010-01-08

DCF Diff

-1,287.89

DCF

2,181

Financial Ratios Every Investor Needs

Stock Dividend of TTKHLTCARE

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-07-18 July 18, 25 10 10 2025-07-18 2025-08-24
2024-07-16 July 16, 24 10 10 2024-07-17 2024-08-23
2023-07-18 July 18, 23 10 10 2023-07-18 2023-08-24
2022-07-26 July 26, 22 10 10 2022-07-27 2022-08-23
2021-08-12 August 12, 21 6 6 2021-08-14 2021-09-07

Stock Rating Details for TTKHLTCARE

Metric Value Recommendation
Overall Rating C Sell
DCF Score 5 Strong Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 872.75 Cr 368.92 Cr 503.83 Cr 0.5773 0.16 Cr 153.83 Cr 352.92 Cr 81.66 Cr 57.79 106.08 Cr 0.0936
2024-03-31 747.64 Cr 340.54 Cr 407.10 Cr 0.5445 1.13 Cr 13.11 Cr 146.33 Cr 62.84 Cr 44.47 99.93 Cr 0.0841
2023-03-31 725.11 Cr 347.78 Cr 377.34 Cr 0.5204 1.32 Cr 10.46 Cr 18.68 Cr 639.71 Cr 452.73 79.68 Cr 0.8822
2022-03-31 599.24 Cr 287.02 Cr 309.06 Cr 0.5157 2.93 Cr 10.11 Cr 9.28 Cr 41.59 Cr 29.43 40.66 Cr 0.0694
2021-03-31 476.06 Cr 254.00 Cr 138.05 Cr 0.2900 2.65 Cr 9.11 Cr 7.04 Cr 46.44 Cr 32.87 37.35 Cr 0.0976

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 9.01 Cr 1,281.19 Cr 216.14 Cr 1,065.0482 Cr 24.22 Cr -762.27 Cr 108.59 Cr 80.98 Cr 0.00 Cr 0.00 Cr 78.12 Cr 210.9231 Cr
2024-03-31 10.96 Cr 1,200.59 Cr 199.68 Cr 1,000.9189 Cr 22.81 Cr 11.85 Cr 96.99 Cr 75.59 Cr 0.00 Cr 0.00 Cr -795.88 Cr 195.8164 Cr
2023-03-31 9.32 Cr 1,170.11 Cr 216.73 Cr 953.3841 Cr 27.33 Cr 18.01 Cr 84.51 Cr 73.94 Cr 56.57 Cr 1.70 Cr 14.11 Cr 210.7799 Cr
2022-03-31 14.86 Cr 558.55 Cr 228.92 Cr 329.6314 Cr 22.21 Cr 7.35 Cr 78.92 Cr 80.48 Cr 90.81 Cr 1.89 Cr 15.13 Cr 220.5344 Cr
2021-03-31 9.55 Cr 494.27 Cr 199.63 Cr 294.6464 Cr 19.14 Cr 9.59 Cr 70.30 Cr 86.12 Cr 68.47 Cr 1.81 Cr 13.17 Cr 188.7626 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -3.9757 Cr 20.1034 Cr -18.0806 Cr -16.8155 Cr -1.9529 Cr 9.0064 Cr -12.8398 Cr 81.6569 Cr 0.4621 Cr -14.1303 Cr -11.5988 Cr
2024-03-31 -4.9433 Cr 28.4935 Cr -21.9112 Cr -15.3267 Cr 1.6390 Cr 10.9593 Cr -10.3834 Cr 62.8419 Cr -4.0553 Cr -14.1303 Cr -12.4752 Cr
2023-03-31 -26.0762 Cr 32.9586 Cr -12.4263 Cr -37.7753 Cr -5.5439 Cr 9.3203 Cr -11.6991 Cr 838.0748 Cr 5.1439 Cr -14.1303 Cr 1.9100 Cr
2022-03-31 44.9963 Cr -30.5473 Cr -5.1772 Cr 38.5016 Cr 5.3094 Cr 14.8642 Cr -6.4947 Cr 57.7787 Cr -0.4602 Cr -8.4782 Cr -16.1207 Cr
2021-03-31 96.4211 Cr -77.2390 Cr -17.1562 Cr 94.6884 Cr 2.0259 Cr 9.5548 Cr -1.7327 Cr 37.0519 Cr -10.6933 Cr -4.2391 Cr 1.3409 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 209.30 Cr 141.57 Cr 67.73 Cr 0.3236 4.92 Cr 10.53 Cr 7.45 16.99 Cr 0.0503
2025-09-30 203.57 Cr 141.17 Cr 62.40 Cr 0.3065 3.12 Cr 20.39 Cr 14.43 24.35 Cr 0.1001
2025-06-30 226.43 Cr 101.82 Cr 124.61 Cr 0.5503 0.49 Cr 13.00 Cr 9.20 20.61 Cr 0.0574
2025-03-31 190.36 Cr 7.37 Cr 254.25 Cr 1.3356 336.26 Cr 16.15 Cr 11.43 30.61 Cr 0.0848
2024-12-31 204.74 Cr 98.03 Cr 106.71 Cr 0.5212 5.58 Cr 16.73 Cr 11.84 25.53 Cr 0.0817

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 600.89 Cr 0.00 Cr 600.89 Cr 111.54 Cr 102.13 Cr 1,165.47 Cr 78.94 Cr 1,295.55 Cr 210.47 Cr
2025-06-30 0.00 Cr 0.00 Cr 855.12 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,065.05 Cr
2025-03-31 9.01 Cr 846.11 Cr 855.12 Cr 121.80 Cr 108.59 Cr 1,103.89 Cr 80.98 Cr 1,281.19 Cr 216.14 Cr
2024-12-31 0.00 Cr 0.00 Cr 792.84 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,038.77 Cr
2024-09-30 792.84 Cr 0.00 Cr 792.84 Cr 95.81 Cr 105.29 Cr 1,158.46 Cr 79.33 Cr 1,266.61 Cr 227.83 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 13.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 16.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 16.73 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 17.20 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 31.58 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Drug Manufacturers - General

Company Name Symbol Price Market Cap Volume
Cipla Limited CIPLA ₹1,333.50 ₹1,077,175,532,780.00 ₹1,049,578.00
Abbott India Limited ABBOTINDIA ₹26,810.00 ₹569,693,786,620.00 ₹9,947.00
GlaxoSmithKline Pharmaceuticals Limited GLAXO ₹2,487.00 ₹421,312,806,558.00 ₹60,117.00
Gland Pharma Limited GLAND ₹1,688.20 ₹278,141,793,309.00 ₹64,054.00
Pfizer Limited PFIZER ₹4,803.50 ₹219,749,230,662.00 ₹16,656.00
Sanofi Consumer Healthcare India Ltd. SANOFICONR ₹4,536.00 ₹104,466,901,392.00 ₹16,725.00
Sanofi India Limited SANOFI ₹3,667.10 ₹84,455,593,936.00 ₹23,422.00
Marksans Pharma Limited MARKSANS ₹174.06 ₹78,877,681,629.00 ₹409,913.00
SMS Pharmaceuticals Limited SMSPHARMA ₹420.30 ₹39,361,935,600.00 ₹1,366,966.00
Senores Pharmaceuticals Ltd. SENORES ₹759.70 ₹34,986,910,804.00 ₹108,067.00

Key Executives

Senior Vice President of Sales & Marketing - AWD
V Senthil Kumar

Gender: Not Specified

Year Born: 1978

President of Operations (PDD)
Brijj Balaji Singh

Gender: male

Year Born: 1968

President of Finance & Chief Financial Officer
V. K. Durga Prasad

Gender: male

Year Born: 1961

President of Heart Valve Division
K. Sunil

Gender: male

Year Born: 1963

CEO, MD & Director
S. Kalyanaraman

Gender: male

Year Born: 1962

President of Foods Division
S. Ranganath Rao

Gender: male

Year Born: 1965

Executive Chairman
T. T. Raghunathan

Gender: male

Year Born: 1952

Senior Vice President of Finance
V K Srinivasan

Gender: male

Year Born: 1968

President of CPD
Yogesh Yadav

Gender: male

Year Born: 1967

Deputy GM of Legal, Company Secretary & Compliance Officer
Gowry A. Jaishankar

Gender: female

Year Born:

FAQs about TTK Healthcare Limited

Who is the CEO of the company?

The CEO is S. Kalyanaraman.

What is the current market price of the stock?

The current price is ₹892.80.

What is the 52-week price range?

The range is ₹890.05-1398.9.

What is the market capitalization of the company?

The market capitalization is ₹1,261.56 crores.

What is the dividend yield?

The dividend yield is 1.12%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 21.00.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of TTK Healthcare Limited (ISIN: INE910C01018) is a leading Drug Manufacturers - General in India. With a market capitalization of ₹1,261.56 crores and an average daily volume of 4,728 shares, it operates in the Drug Manufacturers - General. The company last declared a dividend of ₹10.